WO2012117909A1 - O/w乳化組成物の製造方法 - Google Patents
O/w乳化組成物の製造方法 Download PDFInfo
- Publication number
- WO2012117909A1 WO2012117909A1 PCT/JP2012/054239 JP2012054239W WO2012117909A1 WO 2012117909 A1 WO2012117909 A1 WO 2012117909A1 JP 2012054239 W JP2012054239 W JP 2012054239W WO 2012117909 A1 WO2012117909 A1 WO 2012117909A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- emulsified
- oil
- aqueous phase
- emulsion
- emulsion composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 83
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 61
- 239000007764 o/w emulsion Substances 0.000 title 1
- 239000000839 emulsion Substances 0.000 claims abstract description 77
- 239000008346 aqueous phase Substances 0.000 claims abstract description 56
- -1 glycerin ester Chemical class 0.000 claims abstract description 47
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 38
- 239000000194 fatty acid Substances 0.000 claims abstract description 38
- 229930195729 fatty acid Natural products 0.000 claims abstract description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 36
- 235000011187 glycerol Nutrition 0.000 claims abstract description 33
- 239000003125 aqueous solvent Substances 0.000 claims abstract description 31
- 239000012071 phase Substances 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 22
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 21
- 238000001816 cooling Methods 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 14
- 238000003756 stirring Methods 0.000 claims abstract description 12
- 238000004945 emulsification Methods 0.000 claims description 14
- 229920005862 polyol Polymers 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 46
- 235000019198 oils Nutrition 0.000 description 46
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 32
- 239000000499 gel Substances 0.000 description 21
- 239000002736 nonionic surfactant Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 13
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 10
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 8
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 8
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 235000019388 lanolin Nutrition 0.000 description 8
- 229940039717 lanolin Drugs 0.000 description 8
- 239000001993 wax Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 235000021357 Behenic acid Nutrition 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 229940116226 behenic acid Drugs 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 229960000735 docosanol Drugs 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- YYVJAABUJYRQJO-UHFFFAOYSA-N isomyristic acid Chemical compound CC(C)CCCCCCCCCCC(O)=O YYVJAABUJYRQJO-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000000646 scanning calorimetry Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- 244000280244 Luffa acutangula Species 0.000 description 2
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- HZNIHBVDUONNSD-UHFFFAOYSA-N 2-ethylhexanoic acid;2-ethyl-2-(hydroxymethyl)propane-1,3-diol Chemical compound CCC(CO)(CO)CO.CCCCC(CC)C(O)=O HZNIHBVDUONNSD-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 241000269837 Artemisia dubia Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- OXPCWUWUWIWSGI-MSUUIHNZSA-N Lauryl oleate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC OXPCWUWUWIWSGI-MSUUIHNZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- XLYOFNOQVPJJNP-DYCDLGHISA-N deuterium hydrogen oxide Chemical compound [2H]O XLYOFNOQVPJJNP-DYCDLGHISA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Definitions
- the present invention relates to a method for producing an O / W emulsified composition, and particularly to a production method excellent in simplicity and economy.
- O / W emulsification using ⁇ -gel formed by higher fatty alcohol and polyoxyethylene nonionic surfactant for the purpose of maintaining the emulsification stability of skin preparations for cosmetics, quasi-drugs, and pharmaceuticals.
- Compositions are used, and are particularly known for use as cosmetics.
- an essential component is added to a water phase in which a humectant and a hydrophilic polyoxyethylene nonionic surfactant are dissolved in water and heated to around 70 ° C.
- a method has been used in which an oil phase in which an oil and a higher alcohol are made uniform at around 70 ° C. is added while stirring with a homogenizer, and the emulsified product is cooled to around 35 ° C. with a cooler such as an onlator (for example, Non-patent document 1).
- the method of cooling after emulsification at around 70 ° C. which has been conventionally performed, is not only wasteful because it requires energy by heating and the use of a heat exchanger, but also for washing after using a cooler such as an on-lator. A large amount of water will be used, which will increase the environmental impact.
- Patent Document 1 includes (A) a hydrophilic nonionic surfactant, (B) a linear higher alcohol having 16 or more carbon atoms, (C) an oil component, and (D) an aqueous solvent that dissolves in water.
- an O / W fine emulsion preparation step of adding water or an aqueous formulation while mixing and stirring to invert the phase into an O / W fine emulsion, and an O / W with an emulsified particle size of 50 to 500 nm A method for producing a fine emulsion external preparation is described.
- the method of Patent Document 1 it is possible to easily produce an O / W fine emulsion that is difficult to prepare by a conventional method using a cooler such as an onlator without using an onlator.
- the O / W fine emulsion obtained by the method of Patent Document 1 is used more refreshingly than the O / W emulsion of the same prescription produced by a conventional method using a cooler such as an onlator. It has sex.
- Patent Document 1 since the method of Patent Document 1 is a method in which a W / O emulsion is once prepared with a specific composition and is converted into a fine O / W emulsion by phase inversion, the composition may be limited. Patent Document 1 does not describe a method for producing an O / W emulsion without going through phase inversion from the W / O emulsion.
- the present invention has been made in view of the circumstances of the background art described above, and a problem to be solved is to provide a method for producing an O / W emulsified composition excellent in simplicity and economy.
- the present inventors have conducted intensive research, and as a result, a straight chain having 16 or more carbon atoms capable of forming an ⁇ gel in water together with a specific nonionic surfactant and the nonionic surfactant.
- O / W emulsified composition having a feeling of use equivalent to that of a conventional method using an onlator or the like by using a part of the aqueous phase for cooling if the amount of the aqueous higher alcohol is controlled and the amount of the aqueous solvent is controlled.
- the inventors have found that it can be manufactured, and have completed the present invention.
- the method for producing an O / W emulsion composition includes: (A) a mono-branched fatty acid POE (0-60) glycerin ester; (B) a linear higher alcohol having 16 or more carbon atoms capable of forming an ⁇ gel in water together with (A), (C) oil and An oil phase containing, (D) A part of the aqueous phase containing water (first aqueous phase) is emulsified at a temperature of 70 ° C. or higher to prepare an emulsified part that is an O / W emulsion, Cooling the emulsified part by mixing with the remaining main aqueous phase (second aqueous phase) at 10-35 ° C. with stirring; The aqueous solvent in the emulsified part is 15% by mass or less.
- the present invention also provides a method for producing an O / W emulsion composition, characterized in that, in the above method, the aqueous solvent is a divalent to trivalent polyol. Further, the present invention provides the method for producing an O / W emulsion composition according to any one of the above, wherein the main aqueous phase is 50 to 75% by mass in the total amount of the O / W emulsion composition. provide.
- the present invention provides the method according to any one of the above, wherein the total amount of (A) mono-branched fatty acid POE (0-60) glycerin ester and (B) a linear higher alcohol having 16 or more carbon atoms is (C )
- a method for producing an O / W emulsified composition characterized in that it is 0.5 to 10 parts by mass with respect to 10 parts by mass of oil.
- the method for producing an O / W emulsified composition according to the present invention it can be easily produced with low energy without using a cooler such as an onlator, and thus it is excellent in economic efficiency. Furthermore, the O / W emulsion composition produced by the production method according to the present invention is equivalent in use to the O / W emulsion composition of the same formulation produced using a cooler such as an onlator. It has a feeling and is excellent in storage stability.
- the method for producing an O / W emulsified composition comprises (A) a monobranched fatty acid POE (0-60) glycerin ester and (B) a carbon number of 16 that can form an ⁇ gel in water together with (A).
- An oil phase containing the above linear higher alcohol, (C) an oil component, and (D) a part of the water phase containing water are emulsified at a temperature of 70 ° C. or higher to provide a high concentration O / W emulsification.
- the emulsified part is prepared and cooled by mixing the emulsified part with the remaining main aqueous phase at 10 to 35 ° C.
- the amount is 15% by mass or less, and an ⁇ -gel is formed at the emulsified particle interface of the obtained O / W emulsion composition.
- the ⁇ -gel refers to an aggregate consisting of a lamellar bimolecular film formed by a surfactant with a linear higher alcohol having 16 or more carbon atoms or an unneutralized fatty acid in the presence of water. .
- (A) Mono-branched fatty acid POE (0-60) glycerin ester used in the present invention is a nonionic surfactant capable of forming an ⁇ gel with (B) a higher alcohol in the aqueous phase.
- (A) a mono-branched fatty acid POE (0-60) glycerin ester is not used and another nonionic surfactant is used, even if an ⁇ gel is formed, preparation of an emulsified part In this case, sufficient emulsification cannot be performed, making it difficult to prepare the emulsified part itself, and the desired O / W emulsified composition may not be obtained.
- the (A) monobranched fatty acid POE (0-60) glycerin ester (also referred to as “POE (0-60) glyceryl monobranched fatty acid ester”) used in the present invention has an average addition mole number of oxyethylene groups of 0 to 60.
- the branched fatty acid monoester of polyoxyethylene glyceryl ether is a saturated branched fatty acid having 16 to 24 carbon atoms, preferably 16 to 20 carbon atoms.
- the branch position is not particularly limited.
- POE means a polyoxyethylene group, and the average added mole number thereof is 0 to 60, preferably 5 to 60.
- one or more (A) mono-branched fatty acid POE (0-60) glycerol esters can be used.
- suitable (A) mono-branched fatty acid POE (0-60) glycerin esters include, for example, those of the following general formula (1).
- R is a residue obtained by removing an OH group from a saturated branched fatty acid having 16 to 24 carbon atoms, preferably 16 to 20 carbon atoms.
- Mono-branched fatty acid POE (0-60) glycerin ester can be easily synthesized by a known method, but it is convenient to use a commercially available nonionic surfactant, for example, EAMALEX GWIS-100 series And Nippon Emulsion Co., Ltd. Further, the mono-branched fatty acid POE (0-60) glycerin ester is preferably hydrophilic, and particularly preferably HLB 6 or higher. In the present invention, a linear fatty acid type nonionic surfactant such as monostearic acid POE glycerin ester can be used in combination with mono-branched fatty acid POE (0-60) glycerin ester.
- the straight chain higher alcohol having 16 or more carbon atoms used in the present invention can form an ⁇ gel in water together with the (A) mono-branched fatty acid POE (0-60) glycerin ester, It is not particularly limited as long as it can be used in the fields of pharmaceuticals, quasi drugs and the like, and examples thereof include cetyl alcohol, stearyl alcohol, behenyl alcohol and the like. A linear saturated higher alcohol having 16 to 24 carbon atoms is preferred. In the present invention, (B) one or more linear higher alcohols having 16 or more carbon atoms can be used. In addition, it is preferable to add batyl alcohol, monoglyceride, etc. on formation of (alpha) gel.
- the mass ratio of (A) monobranched fatty acid POE (0-60) glycerin ester used in the present invention to (B) a straight chain higher alcohol having 16 or more carbon atoms is set within a range not impairing the effects of the present invention. There is no particular limitation. Usually, the mass ratio of (A) :( B) is 1: 2 to 10: 1 in the O / W emulsified part.
- the concentration of (A) mono-branched fatty acid POE (0-60) glycerin ester and (B) straight chain higher alcohol having 16 or more carbon atoms is not particularly limited, but in the O / W emulsion composition,
- the total amount of A) mono-branched fatty acid POE (0-60) glycerin ester and (B) straight chain higher alcohol having 16 or more carbon atoms is (C) 0.5 to 10 parts by mass with respect to 10 parts by mass of oil. It is preferable to do.
- the amount is less than 0.5 parts by mass, since the total amount of (A) and (B) is small, a highly stable O / W emulsion composition may not be obtained. Since there is too much total amount of (A) and (B), there exists a tendency which is unpreferable at the point of a usability
- the oil component (C) used in the present invention is not particularly limited, and any oil component can be used as long as it is usually used in cosmetics, pharmaceuticals and the like.
- the solid oil include oils that are solid at room temperature, which are generally used for cosmetics and external preparations for skin.
- liquid oil examples include oils that are liquid at room temperature, which are generally used for cosmetics and skin external preparations.
- avocado oil evening primrose oil, camellia oil, turtle oil, macadamia nut oil, sunflower oil, almond oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, Wheat germ oil, sasanqua oil, castor oil, flaxseed oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, teaseed oil, kaya oil, rice bran oil, cinnabari oil, Japanese kiri oil, jojoba oil, germ oil Liquid oils such as cetyl octoate, cetyl 2-ethylhexanoate, hexyl decyl dimethyl octanoate, ethyl laurate, hexyl laurate, isopropyl myri
- (C) one or more higher fatty acids are blended in the oil.
- the emulsified particles are further refined, and a more stable O / W emulsion composition is obtained.
- Higher fatty acids are preferably those having 16 to 24 carbon atoms, such as unsaturated fatty acids such as oleic acid, linoleic acid, and linolenic acid, isostearic acid, isopalmitic acid, isomyristic acid, behenic acid, stearic acid, palmitic acid. An acid, myristic acid, etc. are mentioned.
- the higher fatty acid is preferably 0.1 to 3% by mass, more preferably 0.2 to 1.5% by mass in the O / W emulsion composition.
- the aqueous phase containing water (D) used in the present invention contains water as a main medium, and usually contains hydrophilic components used in cosmetics, pharmaceuticals, etc. within a range that does not impair the effects of the present invention. It doesn't matter.
- the total amount of water in the O / W emulsion composition of the present invention is not particularly limited, but is generally 40 to 95% by weight in the total amount of the O / W emulsion composition. preferable.
- the aqueous phase of the O / W emulsion composition of the present invention can contain an aqueous solvent.
- concentration of the aqueous solvent is too high in the emulsified part of the present invention, the preparation of the emulsified part itself cannot be performed, or even if the emulsified part can be prepared, a conventional O / W emulsified composition obtained using an onlator or the like O / W emulsion composition having a feeling of use equivalent to that of the product may not be obtained.
- the storage stability may be insufficient.
- the concentration of the aqueous solvent in the emulsified part is preferably 15% by mass or less, more preferably 3% by mass or less, and particularly preferably 1% by mass or less. It is. In cosmetics and external preparations for skin, a large amount of an aqueous solvent is often blended, but even if the amount of the aqueous solvent in the emulsified part of the present invention is limited as described above, it is for mixing with the emulsified part.
- the amount of the aqueous solvent in the main aqueous phase (second aqueous phase) is not particularly limited. Therefore, the amount of the aqueous solvent in the finally obtained O / W emulsion composition can be freely designed.
- aqueous solvent whose composition is limited in the aqueous phase for preparing emulsified parts
- examples of the aqueous solvent whose composition is limited in the aqueous phase for preparing emulsified parts include, for example, an aqueous solvent that is liquid at room temperature and is compatible with water having 0 to 3 hydroxyl groups in the molecule.
- glycol (divalent polyol) has a particularly significant effect on the preparation of emulsified parts.
- the main aqueous phase (second aqueous phase) contains (D) water, and can optionally contain the above-mentioned aqueous solvent and other aqueous solvents.
- the component used for a pharmaceutical etc. can also be included in the range by which the effect of this invention is not impaired.
- the main aqueous phase is preferably 50 to 75% by mass, more preferably 55 to 70% by mass, based on the total amount of the O / W emulsion composition. If the main water phase is less than 50% by mass, a sufficient cooling effect cannot be obtained, and extra cooling energy is required accordingly, resulting in poor economic efficiency. Moreover, when it exceeds 75 mass%, since the water phase of the O / W emulsification part prepared at 70 degreeC or more decreases, it exists in the tendency for preparation of a stable O / W emulsification composition to become difficult.
- the temperature of the main aqueous phase added later is preferably 10 to 35 ° C., particularly preferably 15 to 30 ° C. If it is less than 10 ° C., excessive energy for cooling the main water phase is required, which tends to be inferior in economic efficiency. Moreover, when it exceeds 35 degreeC, since sufficient cooling effect is not acquired and extra cooling energy is needed by that much, it is inferior to economical efficiency.
- exothermic peak temperature was measured by using DSC (Q-2000, TA Instruments, USA) and decreasing the temperature at 1 ° C./min.
- the peak temperature of the exothermic peak measured by DSC is considered to correspond to the melting point of the emulsified part in the production method of the present invention.
- the emulsified part of 70 ° C. or higher and the low temperature main water phase of 10 to 35 ° C. are mixed with stirring, but the temperature of the mixture immediately after the mixing of the low temperature main water phase is high, for example, 40 ° C. or higher.
- variation in viscosity of the obtained O / W emulsion composition may be increased.
- the temperature of the mixture immediately after the mixing of the main aqueous phase and the emulsified part is preferably 35 ° C. ⁇ 2 ° C. or lower. This can be easily controlled by the amount and temperature of the main aqueous phase.
- the O / W emulsified composition produced by the production method of the present invention has a monobranched fatty acid POE (0-60) glycerin ester and a higher alcohol at the interface of emulsified particles composed of an oil phase in the presence of water. In this state, there are aggregates formed of lamellar bimolecular films to be formed, so-called ⁇ gels.
- an emulsified part emulsified at a high concentration using a part of the aqueous phase is prepared at 70 ° C. or higher (preferably 70 to 80 ° C., more preferably 70 to 75 ° C.), The emulsified part and the remaining aqueous phase (main aqueous phase) at 10 to 35 ° C. are gradually mixed with stirring.
- the above-described high-temperature emulsified part is diluted and cooled at once, and an O / W emulsified composition in which an ⁇ -gel is present at the emulsion particle interface is prepared.
- an O / W emulsified composition in which an ⁇ -gel is present at the emulsion particle interface is prepared.
- An apparatus used for emulsification, stirring and the like may be appropriately selected from those normally used, and the apparatus used so far can be used as it is, and no special equipment is required.
- the mixing order of the emulsified part and the main aqueous phase is not particularly limited.
- the O / W emulsion composition obtained by the above production method has a sufficiently small particle diameter of 1 to 7.5 ⁇ m and can exist stably over a wide temperature range for a long time.
- an oil, a higher alcohol, and a hydrophilic nonionic surfactant are added to an aqueous phase in which water, a humectant, and a thickener are dissolved in advance and heated to around 70 ° C.
- a method has been used in which an oil phase obtained by homogenizing an agent at around 70 ° C. and emulsified with stirring by a homogenizer is rapidly cooled to around 35 ° C. using an onlator.
- a lot of energy is wasted due to heating and the use of a heat exchanger, and the consumption of water used in the cooler is increased, resulting in a high environmental load.
- the production method of the present invention it is not necessary to heat a large amount of an aqueous phase without using a cooler such as an onlator during emulsification, so that O / W emulsification can be easily performed with low energy.
- a composition can be produced.
- it is substantially emulsified only by the nonionic surfactant with comparatively small irritation with respect to a human body, it is excellent in safety.
- the method for producing an O / W emulsified composition according to the present invention can be achieved by simply adding an aqueous phase at 10 to 35 ° C. to an emulsified part previously produced at 70 to 80 ° C. Since a good O / W emulsified composition that does not change can be obtained, the conventionally used production process can be greatly simplified.
- the O / W emulsified composition according to the present invention can be suitably applied to, for example, an external composition that can be applied to the body such as skin and hair in cosmetics, medicines, and quasi drugs.
- an external composition that can be applied to the body
- it can be used for skin cosmetics, hair cleansing materials, skin cleansing materials, hair styling products and the like.
- components generally used in cosmetics, pharmaceuticals, and the like can be blended in the O / W emulsion composition according to the present invention within a range that does not impair the effects of the present invention. Examples of such components include the following.
- Thickeners such as methylcellulose, ethylcellulose, gum arabic, and polyvinyl alcohol.
- Organic solvents such as ethanol.
- Antioxidants such as butylhydroxytoluene, tocopherol and phytic acid.
- Antibacterial preservatives such as benzoic acid, salicylic acid, sorbic acid, paraoxybenzoic acid esters (such as ethylparaben and butylparaben), and hexachlorophene.
- Amino acids and salts thereof such as glycine, alanine, valine, leucine, serine, threonine, phenylalanine, tyrosine, aspartic acid, asparagine, glutamine, taurine, arginine, histidine.
- Organic acids such as acyl sarcosine acid (eg, lauroyl sarcosine sodium), glutathione, citric acid, malic acid, tartaric acid, lactic acid, and salts thereof.
- Vitamin A and its derivatives Vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B such as vitamin B12, vitamin B15 and its derivatives, ascorbic acid, ascorbic acid phosphate ( Salt), vitamin C such as ascorbic acid dipalmitate, ⁇ -tocopherol, ⁇ -tocopherol, ⁇ -tocopherol, vitamin E acetate, vitamin E nicotinate and other vitamin E, vitamin D, vitamin H, pantothenic acid, pantethine, etc. Vitamins.
- Nicotinamide benzyl nicotinate, ⁇ -oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalyptol, thymol, inositol, saponins (psychosaponin, carrot saponin, loofah)
- Various drugs such as saponin, muclodisaponin, etc.), pantothenyl ethyl ether, ethinyl estradiol, tranexamic acid, cephalanthin, placenta extract.
- Cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, and laurylamine oxide.
- Metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate and gluconic acid.
- Neutralizing agents such as potassium hydroxide, sodium hydroxide and triethanolamine.
- fragrances, scrub agents, powders, coloring materials, whitening agents, UV protection agents such as UV absorbers and UV scattering agents, and the like can be appropriately blended as long as stability is not impaired.
- Manufacturing method B The oil phase and the first aqueous phase were emulsified at 70 ° C. using a homogenizer to obtain an O / W emulsion (emulsified part). This emulsified part was mixed with the main aqueous phase (second aqueous phase) at 25 ° C. while stirring with a propeller stirrer (250 rpm) to obtain an O / W emulsion composition at 35 ° C. ⁇ 2 ° C.
- Production Example 1-a is an O / W emulsion composition (conventional product) by a conventional method (Production Method A) using an onlator.
- Production Examples 1-1 to 1-5 have the same composition as Production Example 1-a (conventional product), but all are cooled by mixing the low-temperature main water phase without using an onlator (production method) It is an O / W emulsion composition manufactured by B), and the amount of the aqueous solvent (dipropylene glycol) in the emulsified part is different.
- the emulsified parts of Production Examples 1-1 to 1-5 formed an ⁇ gel.
- the aqueous solvent in the emulsified part is 15% by mass or less, further 3% by mass or less, particularly 1% by mass or less. It was considered suitable. Also, from the viewpoint of storage stability, it was considered suitable to adjust the aqueous solvent concentration in the emulsified part as described above.
- Table 2 shows the results when glycerin is used as the aqueous solvent.
- the O / W emulsified compositions obtained in Production Examples 2-1 and 2-2 are all produced by a method (Production Method B) in which cooling is performed by mixing a low-temperature main aqueous phase without using an onlator. Yes, the emulsified part formed an alpha gel.
- the equivalence with the conventional product was evaluated based on the O / W emulsion composition (conventional product) obtained by the method (production method A) using the onlator with the same composition.
- Production Example 2-1 an O / W emulsion composition having the same usability as conventional products and good storage stability was obtained.
- the aqueous solvent in the emulsified part was used. If the concentration was too high, the emulsified part could not be prepared.
- Table 3 shows the results of investigations with different types of nonionic surfactants.
- an O / W emulsion composition was produced by a method of cooling by mixing with a low-temperature main aqueous phase (Production Method B). All the emulsified parts in Table 3 formed ⁇ -gel.
- the evaluation of the equivalence with the conventional product was evaluated based on the O / W emulsion composition (conventional product) produced according to the production method A with the same composition.
- Table 3 when monobranched fatty acid POE (0-60) glycerin ester is used, an O / W emulsified composition having a feeling of use equivalent to that of a conventional product can be obtained. (Production Examples 3-1 to 3-4) were also excellent.
- O / W emulsion was obtained by a method according to Production Method B.
- the viscosity of the obtained emulsion was 4,370 mPa ⁇ s / 30 ° C.
- This emulsion had the same feeling of use as a conventional product having the same composition (O / W emulsion obtained by production method A cooled with an onlator or the like) and was excellent in storage stability.
- Example 2 Emulsion ⁇ Second Aqueous Phase (Main Aqueous Phase)> Purified water to 100 mass% Potassium 4-methoxysalicylate 1.0 Edetic acid disodium 0.05 Glycerin 7.0 Dipropylene glycol 7.0 Butylene glycol 5.0 Succinoglycan 0.04 Carboxyvinyl polymer 0.15 Ethanol 1.0 Phenoxyethanol 0.5 Dipotassium glycyrrhizinate 0.05 ⁇ Oil phase> Triethylhexanoin 4.0 Hydrogenated polydecene 6.0 PEG-60 glyceryl monoisostearate 1.2 PEG-5 glyceryl monostearate 0.8 Behenic acid 0.45 Stearic acid 0.6 Isostearic acid 0.45 Behenyl alcohol 0.95 Batyl alcohol 0.25 Vaseline 2.0 Glyceryl diisostearate 2.0 Lauroyl glutamate di (phytosteryl / octyldodecyl) 0.1
- the viscosity of the obtained emulsion was 3,690 mPa ⁇ s / 30 ° C.
- This emulsion had the same feeling of use as a conventional product having the same composition (O / W emulsion obtained by production method A cooled with an onlator or the like) and was excellent in storage stability.
- Example 3 Emulsion ⁇ Second Aqueous Phase (Main Aqueous Phase)> Purified water to 100 mass% Sodium metaphosphate 0.01 Xylitol 3.0 Glycerin 4.0 Dipropylene glycol 5.0 Xanthan gum 0.1 Carboxyvinyl polymer 0.18 Ethanol 4.0 Phenoxyethanol 0.5 ⁇ Oil phase> Cetyl ethylhexanoate 3.0 Hydrogenated polydecene 3.5 Dimethicone 2.0 PEG-60 glyceryl monoisostearate 1.3 PEG-8 glyceryl monoisostearate 0.7 Behenic acid 0.3 Stearic acid 0.4 Isostearic acid 0.3 Behenyl alcohol 0.3 Batyl alcohol 0.15 ⁇ First aqueous phase (for preparing emulsified parts)> Potassium hydroxide 0.14 Purified water 15.0
- O / W emulsion was obtained by a method according to Production Method B.
- the viscosity of the obtained emulsion was 3,260 mPa ⁇ s / 30 ° C.
- This emulsion had the same feeling of use as a conventional product having the same composition (O / W emulsion obtained by production method A cooled with an onlator or the like) and was excellent in storage stability.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
(A)モノ分岐脂肪酸POE(0-60)グリセリンエステルと、
(B)前記(A)とともに水中でαゲルを形成し得る炭素数16以上の直鎖状高級アルコールと、
(C)油分と、
を含む油相と、
(D)水
を含む水相の一部(第1水相)とを、70℃以上の温度で乳化してO/W乳化物である乳化パーツを調製し、
この乳化パーツを10~35℃の残りの主水相(第2水相)と攪拌しながら混合することにより冷却することを含み、
前記乳化パーツ中における水性溶媒が15質量%以下であることを特徴とする。
また、本発明は、前記何れかに記載の方法において、前記主水相がO/W乳化組成物全量中50~75質量%であることを特徴とするO/W乳化組成物の製造方法を提供する。
好適な(A)モノ分岐脂肪酸POE(0-60)グリセリンエステルの一例としては、例えば、下記一般式(1)のものが挙げられる。
また、モノ分岐鎖脂肪酸POE(0-60)グリセリンエステルとしては親水性であるものが好ましく、特にHLB6以上のものが好ましい。なお、本発明においては、モノ分岐脂肪酸POE(0-60)グリセリンエステルとともに、モノステアリン酸POEグリセリンエステルなどの、直鎖脂肪酸型非イオン性界面活性剤を組み合わせて使用することができる。
なお、αゲルの形成の上では、バチルアルコール、モノグリセライド等を添加することが好ましい。
本発明で用いる(A)モノ分岐脂肪酸POE(0-60)グリセリンエステルと(B)炭素数16以上の直鎖状高級アルコールとの質量比は、本発明の効果が損なわれない範囲で設定すればよく、特に制限されるものではない。通常は(A):(B)の質量比はO/W乳化パーツ中1:2~10:1である。
固形油分としては、一般に化粧料や皮膚外用剤に用いられる室温において固体の油分が挙げられる。具体的に示すとすれば、例えば、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化脂、牛脚脂、モクロウ、硬化ヒマシ油等の固体油脂;ミツロウ、キャンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、POE水素添加ラノリンアルコールエーテル等のロウ類;ポリエチレンワックス、パラフィンワックス、セレシン、ワセリン、マイクロクリスタリンワックス、ルナセラ、オゾケライト等の炭化水素系ワックス;モノステアリルグリセリンエーテル(バチルアルコール)等の脂肪酸グリセリルエーテル;アセトグリセライド、トリ-2-ヘプチルウンデカン酸グリセライド等の脂肪酸グリセリド等が挙げられる。これらの固形油分は、それぞれ単独ないしは2種以上を組み合わせて配合することができる。
なお、本発明のO/W乳化組成物における水の総配合量は、特に限定されるものではないが、一般的には、O/W乳化組成物全量中40~95重量%であることが好ましい。
従って、乳化パーツ中において水性溶媒を含まないことが好ましく、含む場合には乳化パーツ中における水性溶媒の濃度は15質量%以下、さらには3質量%以下、特に1質量%以下とすることが好適である。
なお、化粧料や皮膚外用剤では、水性溶媒が多量に配合されることが多いが、本発明の乳化パーツ中の水性溶媒量は上記のように制限されても、乳化パーツとの混合用の主水相(第2水相)中の水性溶媒量は特に制限されない。よって、最終的に得られるO/W乳化組成物中の水性溶媒量は自由に設計することができる。
これらのうち、グリコール(2価ポリオール)は乳化パーツ調製に及ぼす影響が特に著しい。
該主水相は、O/W乳化組成物全量中50~75質量%が好ましく、55~70質量%がより好ましい。主水相が、50質量%未満であると十分な冷却効果が得られず、その分余計な冷却エネルギーを必要とするため、経済性に劣る。また、75質量%を超えると70℃以上で調製するO/W乳化パーツの水相が少なくなるために、安定なO/W乳化組成物の調製が困難になる傾向にある。
なお、DSC測定において、αゲル形成による発熱ピークの他にも発熱ピークが検出されることがある。これは、乳化パーツ中に含まれる成分の単なる凝固による発熱ピークであり、αゲル形成による発熱ピークはこれら凝固による発熱ピークとは異なる。
なお、本発明において発熱ピーク温度の測定は、DSC(Q-2000,TA Instruments,USA)を用い、1℃/分で降温させて測定した。
概念
(A)モノ分岐脂肪酸POE(0-60)グリセリンエステルと(B)前記(A)とともに水中でαゲルを形成し得る炭素数16以上の直鎖状高級アルコールと(C)油分とを含む油相と、(D)水を含む水相とを70℃以上の温度で乳化し、これを冷却する工程によりO/W乳化組成物が得られる。
よって、上記問題を解消するために、水相の一部を用いて高濃度に乳化された乳化パーツを70℃以上(好ましくは70~80℃、さらに好ましくは70~75℃)で調製し、上記乳化パーツと10~35℃の残りの水相(主水相)とを攪拌しながら徐々に混合する。この低温主水相の混合により、上述の高温乳化パーツが希釈されるとともに一気に冷却され、αゲルが乳化粒子界面に存在するO/W乳化組成物が調製される。ただし、このような方法において乳化パーツ中における水性溶媒濃度が高すぎると使用性や保存安定性に優れるO/W乳化組成物が得られない。よって、本発明においては、水性溶媒を乳化パーツ中15質量%以下とすることが必要である。乳化、攪拌などに用いる装置は通常使用されているものから適宜選択すればよく、それまで使用していた装置をそのまま利用することができ、特別の設備は不要である。乳化パーツと主水相との混合順序も特に制限されない。
また、本発明にかかるO/W乳化組成物には、上記必須成分の他に、通常、化粧品、医薬品等に用いられる成分を本発明の効果を損なわない範囲で配合することができる。かかる成分としては、例えば次のようなものが挙げられる。
また、その他、香料、スクラブ剤、粉末、色材、美白剤、紫外線吸収剤や紫外線散乱剤などの紫外線防御剤なども、安定性などを損なわない範囲で適宜配合することができる。
まず、本発明で用いた試験法・評価法について説明する。
B型粘度計(ローター番号3番、ローター回転数12rpm)を用い、30℃における粘度を測定した。
調製したO/W乳化組成物を、0℃、25℃、50℃の各温度で1か月間保存した後、製造直後の粘度との差が最大となる温度条件において、下記の評価基準により評価した。
○:粘度変化が10%未満
△:粘度変化が10%以上20%未満
×:粘度変化が20%以上
なお、△以上の評価を合格とした。
10名のパネルにより試験を行い、使用感(のび、なじみ、べたつき、みずみずしさ、こく)の総合評価として従来品(同一組成でオンレータを用いて製造したO/W乳化組成物)と同等であると回答した人数が、
○:8名以上
△:5名以上7名以下
×:4名以下
とし、△以上の評価を合格とした。
油相をホモゲナイザーで攪拌しながら第1水相及び第2水相を加え、70℃にて乳化し調製したO/Wエマルションをオンレーターに通過させて35℃まで冷却し、その後室温まで放冷してO/W乳化組成物を得た。
油相及び第1水相をホモゲナイザーを用いて70℃で乳化してO/Wエマルション(乳化パーツ)を得た。この乳化パーツを25℃の主水相(第2水相)にプロペラ攪拌機(250rpm)で攪拌しながら混合し、35℃±2℃のO/W乳化組成物を得た。
製造例1-aはオンレータを用いた従来法(製造方法A)によるO/W乳化組成物(従来品)である。
一方、製造例1-1~1-5は、製造例1-a(従来品)と同一組成であるものの、何れもオンレータを使用せずに低温主水相の混合により冷却する方法(製造方法B)により製造されたO/W乳化組成物であり、乳化パーツ中の水性溶媒(ジプロピレングリコール)の量がそれぞれ異なっている。製造例1-1~1-5の乳化パーツは、αゲルを形成した。
このようなことから、従来品と同等の使用感のO/W乳化組成物を得るためには、乳化パーツ中の水性溶媒を15質量%以下、さらには3質量%以下、特に1質量%以下とすることが好適であると考えられた。また、保存安定性の点からも、上記のように乳化パーツ中の水性溶媒濃度を調整することが好適であると考えられた。
製造例2-1では、従来品と同等の使用感を有し、保存安定性も良好なO/W乳化組成物が得られたが、製造例2-2のように乳化パーツ中の水性溶媒濃度が高すぎると、乳化パーツの調製ができなかった。
表3のように、モノ分岐脂肪酸POE(0-60)グリセリンエステルを用いた場合には、従来品と同等の使用感を有するO/W乳化組成物が得られ、またこれらは保存安定性にも優れていた(製造例3-1~3-4)。
このようなことから、本発明においては、モノ分岐脂肪酸POE(0-60)グリセリンエステルを用いることが重要であることが理解される。
<第2水相(主水相)>
精製水 to 100 質量%
トラネキサム酸 2.0
エデト酸2ナトリウム 0.01
キシリトール 3.0
グリセリン 3.0
ジプロピレングリコール 7.0
キサンタンガム 0.05
カルボキシビニルポリマー 0.1
エタノール 3.0
フェノキシエタノール 0.5
<油相>
エチルヘキサン酸セチル 4.0
流動パラフィン 3.5
モノイソステアリン酸PEG-60グリセリル 1.0
モノステアリン酸PEG-5グリセリル 1.0
ベヘニン酸 0.3
ステアリン酸 0.4
イソステアリン酸 0.3
ベヘニルアルコール 0.3
バチルアルコール 0.15
ワセリン 0.5
ジメチコン 1.0
<第1水相(乳化パーツ調製用)>
水酸化カリウム 0.08
精製水 15.0
製造方法Bに準じた方法により、O/W乳液を得た。得られた乳液の粘度は4,370mPa・s/30℃であった。この乳液は、同じ組成の従来品(オンレータ等で冷却する製造方法Aで得られたO/W乳液)と同等の使用感を有し、また保存安定性にも優れていた。
<第2水相(主水相)>
精製水 to 100 質量%
4-メトキシサリチル酸カリウム 1.0
エデト酸2ナトリウム 0.05
グリセリン 7.0
ジプロピレングリコール 7.0
ブチレングリコール 5.0
サクシノグリカン 0.04
カルボキシビニルポリマー 0.15
エタノール 1.0
フェノキシエタノール 0.5
グリチルリチン酸ジカリウム 0.05
<油相>
トリエチルヘキサノイン 4.0
水添ポリデセン 6.0
モノイソステアリン酸PEG-60グリセリル 1.2
モノステアリン酸PEG-5グリセリル 0.8
ベヘニン酸 0.45
ステアリン酸 0.6
イソステアリン酸 0.45
ベヘニルアルコール 0.95
バチルアルコール 0.25
ワセリン 2.0
ジイソステアリン酸グリセリル 2.0
ラウロイルグルタミン酸
ジ(フィトステリル/オクチルドデシル) 0.1
ジメチコン 2.0
メチルフェニルポリシロキサン 1.5
<第1水相(乳化パーツ調製用)>
トリエタノールアミン 1.5
精製水 15.0
<製造方法>
製造方法Bに準じた方法により、O/W乳液を得た。得られた乳液の粘度は3,690mPa・s/30℃であった。この乳液は、同じ組成の従来品(オンレータ等で冷却する製造方法Aで得られたO/W乳液)と同等の使用感を有し、また保存安定性にも優れていた。
<第2水相(主水相)>
精製水 to 100 質量%
メタリン酸ナトリウム 0.01
キシリトール 3.0
グリセリン 4.0
ジプロピレングリコール 5.0
キサンタンガム 0.1
カルボキシビニルポリマー 0.18
エタノール 4.0
フェノキシエタノール 0.5
<油相>
エチルヘキサン酸セチル 3.0
水添ポリデセン 3.5
ジメチコン 2.0
モノイソステアリン酸PEG-60グリセリル 1.3
モノイソステアリン酸PEG-8グリセリル 0.7
ベヘニン酸 0.3
ステアリン酸 0.4
イソステアリン酸 0.3
ベヘニルアルコール 0.3
バチルアルコール 0.15
<第1水相(乳化パーツ調製用)>
水酸化カリウム 0.14
精製水 15.0
製造方法Bに準じた方法により、O/W乳液を得た。得られた乳液の粘度は3,260mPa・s/30℃であった。この乳液は、同じ組成の従来品(オンレータ等で冷却する製造方法Aで得られたO/W乳液)と同等の使用感を有し、また保存安定性にも優れていた。
Claims (4)
- (A)モノ分岐脂肪酸POE(0-60)グリセリンエステルと、
(B)前記(A)とともに水中でαゲルを形成し得る炭素数16以上の直鎖状高級アルコールと、
(C)油分と、
を含む油相と、
(D)水
を含む水相の一部(第1水相)とを、70℃以上の温度で乳化してO/W乳化物である乳化パーツを調製し、
この乳化パーツを10~35℃の残りの主水相(第2水相)と攪拌しながら混合することにより冷却することを含み、
前記乳化パーツ中における水性溶媒が15質量%以下であることを特徴とするO/W乳化組成物の製造方法。 - 請求項1記載の方法において、水性溶媒が2~3価のポリオールであることを特徴とするO/W乳化組成物の製造方法。
- 請求項1又は2記載の方法において、前記主水相がO/W乳化組成物全量中50~75質量%であることを特徴とするO/W乳化組成物の製造方法。
- 請求項1~4の何れかに記載の方法において、(A)モノ分岐脂肪酸POE(0-60)グリセリンエステルと(B)炭素数16以上の直鎖状高級アルコールの合計量が、(C)油分10質量部に対して0.5~10質量部であることを特徴とするO/W乳化組成物の製造方法。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112013022072A BR112013022072A2 (pt) | 2011-03-01 | 2012-02-22 | método de produção de composição de emulsão o/a |
CN201280011063.6A CN103458855B (zh) | 2011-03-01 | 2012-02-22 | O/w乳化组合物的制备方法 |
US14/001,680 US20130331468A1 (en) | 2011-03-01 | 2012-02-22 | Production Method Of O/W Emulsion Composition |
HK14101241.9A HK1188133B (en) | 2011-03-01 | 2012-02-22 | Manufacturing method for o/w emulsion composition |
KR1020137025384A KR20140012695A (ko) | 2011-03-01 | 2012-02-22 | O/w 유화조성물의 제조방법 |
EP12752276.1A EP2682094A4 (en) | 2011-03-01 | 2012-02-22 | METHOD OF MANUFACTURING OIL-IN-WATER EMULSION COMPOSITION |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011043593 | 2011-03-01 | ||
JP2011-043593 | 2011-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012117909A1 true WO2012117909A1 (ja) | 2012-09-07 |
Family
ID=46757848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2012/054239 WO2012117909A1 (ja) | 2011-03-01 | 2012-02-22 | O/w乳化組成物の製造方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20130331468A1 (ja) |
EP (1) | EP2682094A4 (ja) |
JP (1) | JP5244989B2 (ja) |
KR (1) | KR20140012695A (ja) |
CN (1) | CN103458855B (ja) |
BR (1) | BR112013022072A2 (ja) |
TW (1) | TWI532502B (ja) |
WO (1) | WO2012117909A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015227305A (ja) * | 2014-05-30 | 2015-12-17 | 花王株式会社 | 皮膚化粧料 |
KR101840160B1 (ko) * | 2014-06-13 | 2018-03-19 | 가부시키가이샤 시세이도 | α겔 중간체 조성물 및 상기 조성물을 사용한 α겔 함유 O/W 유화화장료의 제조방법 |
WO2015190306A1 (ja) * | 2014-06-13 | 2015-12-17 | 株式会社 資生堂 | αゲル中間体組成物、及び該組成物を用いたαゲル含有O/W乳化化粧料の製造方法 |
JP6548265B2 (ja) * | 2015-03-06 | 2019-07-24 | 国立大学法人信州大学 | エマルション |
ITUB20154642A1 (it) * | 2015-10-13 | 2017-04-13 | Bakel Srl | Metodo di preparazione di un prodotto in crema |
WO2017081725A1 (ja) * | 2015-11-09 | 2017-05-18 | 花王株式会社 | 口腔用組成物 |
HUE047368T2 (hu) * | 2017-07-17 | 2020-04-28 | Dr August Wolff Gmbh & Co Kg Arzneimittel | Olaj-a-vízben emulzió |
EP3834810A4 (en) * | 2018-08-10 | 2022-05-04 | Shiseido Company, Ltd. | Emulsion cosmetic |
CN109464302B (zh) * | 2018-12-29 | 2021-11-23 | 上海家化联合股份有限公司 | 含甘草酸二钾的组合物 |
WO2020179947A1 (ko) * | 2019-03-06 | 2020-09-10 | 코스맥스 주식회사 | 입자 형태의 유상을 가지는 화장료 조성물을 제조하는 방법 및 그에 의해 제조된 화장료 조성물 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008044866A (ja) * | 2006-08-11 | 2008-02-28 | Shiseido Co Ltd | クリーム組成物 |
WO2008117481A1 (ja) * | 2007-03-22 | 2008-10-02 | Noevir Co., Ltd. | 皮膚外用剤及び飲食品 |
WO2010082602A1 (ja) | 2009-01-14 | 2010-07-22 | 株式会社 資生堂 | O/w微細エマルション外用剤の製造方法 |
WO2011027811A1 (ja) * | 2009-09-04 | 2011-03-10 | 株式会社 資生堂 | O/w乳化組成物の製造方法 |
WO2011027812A1 (ja) * | 2009-09-04 | 2011-03-10 | 株式会社 資生堂 | 高粘度o/wクリームの製造方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001006993A1 (fr) * | 1999-07-27 | 2001-02-01 | Shiseido Company, Ltd. | Composition d'emulsion huile dans l'eau |
-
2012
- 2012-02-22 BR BR112013022072A patent/BR112013022072A2/pt not_active IP Right Cessation
- 2012-02-22 WO PCT/JP2012/054239 patent/WO2012117909A1/ja active Application Filing
- 2012-02-22 CN CN201280011063.6A patent/CN103458855B/zh active Active
- 2012-02-22 KR KR1020137025384A patent/KR20140012695A/ko not_active Withdrawn
- 2012-02-22 US US14/001,680 patent/US20130331468A1/en not_active Abandoned
- 2012-02-22 EP EP12752276.1A patent/EP2682094A4/en not_active Withdrawn
- 2012-02-22 JP JP2012035831A patent/JP5244989B2/ja active Active
- 2012-02-24 TW TW101106182A patent/TWI532502B/zh not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008044866A (ja) * | 2006-08-11 | 2008-02-28 | Shiseido Co Ltd | クリーム組成物 |
WO2008117481A1 (ja) * | 2007-03-22 | 2008-10-02 | Noevir Co., Ltd. | 皮膚外用剤及び飲食品 |
WO2010082602A1 (ja) | 2009-01-14 | 2010-07-22 | 株式会社 資生堂 | O/w微細エマルション外用剤の製造方法 |
WO2011027811A1 (ja) * | 2009-09-04 | 2011-03-10 | 株式会社 資生堂 | O/w乳化組成物の製造方法 |
WO2011027812A1 (ja) * | 2009-09-04 | 2011-03-10 | 株式会社 資生堂 | 高粘度o/wクリームの製造方法 |
Non-Patent Citations (2)
Title |
---|
MANABU SENOO: "Chemistry and Application of Surface Activity", 1995, DAINIPPON TOSHO CO., LTD., pages: 159 - 160 |
See also references of EP2682094A4 * |
Also Published As
Publication number | Publication date |
---|---|
US20130331468A1 (en) | 2013-12-12 |
HK1188133A1 (zh) | 2014-04-25 |
TW201240675A (en) | 2012-10-16 |
EP2682094A1 (en) | 2014-01-08 |
CN103458855B (zh) | 2016-03-30 |
JP5244989B2 (ja) | 2013-07-24 |
CN103458855A (zh) | 2013-12-18 |
KR20140012695A (ko) | 2014-02-03 |
JP2012193168A (ja) | 2012-10-11 |
TWI532502B (zh) | 2016-05-11 |
EP2682094A4 (en) | 2014-09-10 |
BR112013022072A2 (pt) | 2016-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4709320B2 (ja) | O/w乳化組成物の製造方法 | |
JP5244989B2 (ja) | O/w乳化組成物の製造方法 | |
JP5047369B2 (ja) | O/w微細エマルション外用剤の製造方法 | |
JP4729126B2 (ja) | 高粘度o/wクリームの製造方法 | |
US7763237B2 (en) | Ultraviolet protective preparation and cosmetics containing the same | |
JP6281744B2 (ja) | 水中油型乳化化粧料 | |
JP2009203200A (ja) | 水中油型乳化組成物 | |
JP6133618B2 (ja) | 油中水型乳化組成物 | |
JP2012140342A (ja) | 水中油型乳化日焼け止め化粧料 | |
JP2023157265A (ja) | 乳化化粧料 | |
JP2021123590A (ja) | 油中水型乳化化粧料 | |
JP2010222317A (ja) | 水中油型乳化化粧料 | |
JPH11228378A (ja) | 乳化化粧料 | |
JP4039542B2 (ja) | O/w/o型複合エマルジョン | |
JP5824323B2 (ja) | 油中水型乳化組成物 | |
JPH11286418A (ja) | 水中油型毛髪化粧料 | |
JP2007269668A (ja) | 水中油型美白化粧料 | |
JP2024011463A (ja) | 水中油型乳化化粧料 | |
JP2007169174A (ja) | O/w型乳化組成物 | |
HK1188133B (en) | Manufacturing method for o/w emulsion composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201280011063.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12752276 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14001680 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2012752276 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012752276 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20137025384 Country of ref document: KR Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013022072 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013022072 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130829 |